A significant breakthrough in cancer study is arising with the use of VHH fragments to restore dysfunctional p53. This essential malignant protector protein is frequently disabled in several forms of cancer, leading https://push2bookmark.com/story22133447/mini-antibodies-restore-tumor-suppressor-p53-the-potential-pathway-for-cancer-therapy